Resources
What the research actually says
We'd rather point you to real data than just tell you to trust us. Here's a curated set of independent research, journalism, and clinical studies on medical tourism — the encouraging findings and the sobering ones both.
The industry, by the numbers
Independent market analysts and industry observers, paraphrased and cited — not quoted.
Independent analysts don't agree on exactly how big medical tourism is — estimates range from roughly $76 billion to over $300 billion depending on what's counted — but they agree on the trajectory: consistent double-digit annual growth, driven by high U.S. healthcare costs, longer domestic wait times, and sustained investment in international-patient infrastructure abroad.
Cosmetic procedures are the largest single category in the industry, and Turkey alone holds the largest share of any single country's market.
By most counts, something like 14 to 16 million people cross a border for medical care every year, saving an estimated 40 to 90 percent compared to U.S. list prices for equivalent procedures.
Safety, accreditation, and outcomes: read the real data
The CDC, peer-reviewed clinical studies, and JCI's own standards — the reassuring numbers and the caveats, side by side.
The CDC's own guidance for medical tourists is direct: infection-related complications are the most common risk, accreditation standards vary significantly by country, and patients should consult a home physician or travel-medicine specialist well before departure. It's exactly the kind of caution worth reading before booking anything — including with us.
When researchers look specifically at accredited hospitals, the picture gets more reassuring: a 2019 analysis found infection rates at accredited Turkish hospitals in the same range as Western Europe and North America. A 2025 study of a high-volume international surgical center found an overall complication rate of 6.2% and tummy-tuck-specific complications at 5.5% — both lower than the U.S. benchmark databases they were compared against.
Source: Journal of Medical Tourism, via Turquie Santé·Plastic and Reconstructive Surgery – Global Open, 2025
That's not the whole picture, and it shouldn't be presented as one. A 2026 systematic review found the published evidence on cosmetic-tourism complications and costs is still fragmented, and a separate 12-year review at one tertiary hospital documented real complications, including severe infections, among patients who had traveled for cosmetic procedures. Taken together, the honest read of this research is that outcomes vary enormously by hospital, not by country — which is exactly why accreditation verification and surgeon-specific case volume matter more than which flag is on the building.
Source: Journal of Plastic, Reconstructive & Aesthetic Surgery, 2026·Aesthetic Plastic Surgery, 2025
JCI accreditation — the standard verified for every Bello partner hospital — was updated in 2025 with a new patient-safety framework, the SAFER Matrix, designed to prioritize the risks that matter most rather than a flat checklist.
Bangkok, specifically
Accreditation counts and hospital-level data for the city we send the most patients to.
Thailand has more JCI-accredited hospitals than any other country in Southeast Asia — 65 as of 2026 — with the deepest concentration in Bangkok. Bumrungrad International has held continuous JCI accreditation since 2002 and now treats more than 1.1 million patients a year from 190 countries.
Source: Konkai Health — JCI-Accredited Hospitals in Thailand·Bumrungrad International — Hospital Factsheet & Accreditation
Newsweek named MedPark Hospital one of Thailand's best hospitals for the fifth consecutive year in 2026, alongside a renewed JCI accreditation term.
Source: MedPark Hospital — Newsweek World's Best Hospitals 2026
This list will grow as we add more research on our other destination cities. If you've read something that should be here, tell your coordinator or reach out directly.